- 全部删除
您的购物车当前为空
Remibrutinib 是有效的、口服具有活力的 bruton tyrosine kinase 抑制剂 (IC50:1 nM),在血液中抑制 BTK 活性的 IC50的值为 0.23 μM。它具有研究慢性荨麻疹的潜力。


为众多的药物研发团队赋能,
让新药发现更简单!
Remibrutinib 是有效的、口服具有活力的 bruton tyrosine kinase 抑制剂 (IC50:1 nM),在血液中抑制 BTK 活性的 IC50的值为 0.23 μM。它具有研究慢性荨麻疹的潜力。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 848 | In stock | |
| 5 mg | ¥ 2,050 | In stock | |
| 10 mg | ¥ 3,310 | In stock | |
| 25 mg | ¥ 5,400 | In stock | |
| 50 mg | ¥ 7,560 | In stock | |
| 100 mg | ¥ 10,100 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,270 | In stock |
Remibrutinib 相关产品
| 产品描述 | Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticaria (CU) treatment. |
| 靶点活性 | CD69 (Cell-free assay):18 nM, BTK (Cell-free assay):1.3 nM, IL-8 (Cell-free assay):2.5 nM, BTK:1 nM, Btk enzymatic (B cell):0.023 μM |
| 体外活性 | Remibrutinib inhibits Btk enzymatic activity (IC50: 1 nM in a biochemical enzyme assay). Remibrutinib inhibits Btk enzymatic activity in the blood (IC50: 0.023 μM in vitro B cell activation assay), the whole blood is collected from the abdominal aorta of anesthetized adult male Lewis rats[1]. |
| 分子量 | 507.53 |
| 分子式 | C27H27F2N5O3 |
| CAS No. | 1787294-07-8 |
| Smiles | CN(CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(cc2F)C2CC2)c1C)C(=O)C=C |
| 密度 | 1.332 g/cm3 (Predicted) |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 240 mg/mL (472.88 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容